COMP <GO>
ACTG vs DLB // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Acacia Research Corporation (Acacia Tech) (NASDAQ) VS. Dolby Laboratories (NYSE) • 15-METRIC TALLY: ACTG 3
— DLB 9
■ METRIC PARITY
LAST: $4.22 (-2.54%) • MKT CAP: $422.6M
options-implied-move
—
LAST: $63.28 (+2.08%) • MKT CAP: $5.81B
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ACTG VS. DLB)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ACTG | DLB | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 29.60% | 88.10% | -58.50 | DLB | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 2.10% | 9.50% | -7.40 | DLB | /roic <GO> |
| EV/EBITDA & P/E Valuation | 33.8x | 18.6x | +15.20 | DLB | /valuation <GO> |
| Free Cash Flow Yield | 17.37% | 7.40% | +9.97 | ACTG | /fcf-yield <GO> |
| Operating Margin | 2.20% | 19.60% | -17.40 | DLB | /operating-margins <GO> |
| Net Profit Margin | 8.60% | 18.90% | -10.30 | DLB | /net-margins <GO> |
| Revenue Growth (YoY) | 133.20% | 5.90% | +127.30 | ACTG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.15% | -2.15 | DLB | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.95 | 8.20 | -6.25 | DLB | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 50.1 | 54.0 | -3.90 | DLB | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.00 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 14.9x | 21.5x | -6.60 | ACTG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $422.6M | $5.81B | -$5.38B | DLB | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ACTG REV | DLB REV | ACTG GROSS % | DLB GROSS % | ACTG FCF | DLB FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $285.2M | $1.35B | 29.6% | 88.1% | $75.2M | $435.9M |
| FY 2024 | $122.3M | $1.27B | 24.2% | 89.0% | -$98.5M | $297.2M |
| FY 2023 | $125.1M | $1.30B | — | — | -$22.5M | $308.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ACTG // BETA —
DLB // BETA 1.00